Send Inquiry

Request To Call Back

DACIHEP DACLATASVIR TABLETS

Get a Price/Quote

DACIHEP DACLATASVIR TABLETS Specification

Salt Composition
Daclatasvir 60 mg

Origin of Medicine
India

Pacakaging (Quantity Per Box)
28 tablets

Indication
Treatment of Hepatitis C virus (HCV)

Dosage Form
Tablet

Drug Type
Allopathic

Ingredients
Daclatasvir Dihydrochloride

Physical Form
Tablets

Function
Antiviral medication

Recommended For
Chronic Hepatitis C Infection

Dosage
60 mg as prescribed by physician

Dosage Guidelines
Take orally, as directed by healthcare provider

Suitable For
Adults

Quantity
28 tablets per box

Storage Instructions
Store in a cool, dry place below 30C

Shelf Life
24 months

Drug Strength
60 mg

Colour
Film-coated

Product Code
Dacihep

Contraindications
Known hypersensitivity to Daclatasvir or any component of the tablet

Route of Administration
Oral

MRP
As per company's latest price list

Brand Name
Dacihep

Prescription/Non Prescription
Prescription

Warning
To be sold by retail on the prescription of a registered medical practitioner only

Side Effects
Fatigue, headache, nausea, anemia (see leaflets for detail)

Therapeutic Class
Antiviral agents

Marketed By
Zydus Cadila

Packing Type
Blister pack

DACIHEP DACLATASVIR TABLETS Trade Information

Packaging Details
PACK FO 28 TABLETS

Main Domestic Market
All India

About DACIHEP DACLATASVIR TABLETS

Dacihep Tablets / Dacihep - Daclatasvir

Specification :-

Brand Name : Dacihep
Content : Daclatasvir
Form : Tablet
Strength : 60 Mg
Packing : Pack Of 28 Tablet
Manufactured By : Zydus Heptiza

Note :- Dacihep Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug...........

Targeted Hepatitis C Therapy

Dacihep tablets are designed specifically for the management of chronic Hepatitis C virus (HCV) infection. Its active ingredient, Daclatasvir, is an antiviral agent that directly acts to inhibit viral replication. This treatment is recommended for adults and should only be used under medical supervision for optimal outcomes.

Strict Prescription Guidelines

Dacihep is a prescription-only medication. It should be dispensed and taken strictly as directed by a registered medical practitioner. Self-medication or unsupervised usage may lead to adverse reactions, including fatigue, nausea, headache, and anemia, or other serious complications. Always consult your doctor before starting or discontinuing therapy.

Convenient Dosage and Storage

Each box of Dacihep contains 28 film-coated tablets, each with 60 mg of Daclatasvir. Tablets are administered orally in accordance with your physicians instructions. Ensure to store the tablets in a cool, dry location below 30C to maintain efficacy and prolong shelf life. Proper storage safeguards the integrity of the medication.

FAQs of DACIHEP DACLATASVIR TABLETS:

Q: How should I take Dacihep Daclatasvir Tablets?

A: Dacihep should be taken orally, following the dosage and frequency prescribed by your healthcare provider. Do not alter the dose or stop the treatment without consulting your physician.

Q: What are the primary benefits of using Dacihep?

A: Dacihep is effective in treating adults with chronic Hepatitis C infection by inhibiting viral replication, which can help reduce liver damage and improve overall health outcomes with proper use.

Q: When is Dacihep recommended for use?

A: Dacihep is recommended for adults diagnosed with chronic Hepatitis C, as confirmed by a healthcare provider. It is not suitable for children or those without a prescription.

Q: Where should Dacihep be stored to ensure its efficacy?

A: Store Dacihep in a cool, dry place at a temperature below 30C. Avoid exposure to heat, moisture, and direct sunlight to maintain the quality and effectiveness of the tablets.

Q: What are the possible side effects of Dacihep Tablets?

A: Common side effects may include fatigue, headache, nausea, and anemia. More detailed information can be found in the leaflet provided. Always report any unusual symptoms to your healthcare provider.

Q: Who should not take Dacihep?

A: Individuals with known hypersensitivity to Daclatasvir or any component of the tablet should not take Dacihep. Inform your doctor of all allergies and medications before starting treatment.

Q: What is the process for obtaining Dacihep Tablets?

A: Dacihep can only be purchased from licensed pharmacies or healthcare suppliers with a valid prescription from a registered medical practitioner. It is marketed by Zydus Cadila throughout India.

Tell us about your requirement